Recent Advances in Phosphoproteomics and Application to Neurological Diseases

Overview

Journal Analyst

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2017 Nov 3

PMID 29094114

Citations 17

Authors

Justine V Arrington

Chuan-Chih Hsu

Sarah G Elder

W Andy Tao

Affiliations

Soon will be listed here.

Abstract

Phosphorylation has an incredible impact on the biological behavior of proteins, altering everything from intrinsic activity to cellular localization and complex formation. It is no surprise then that this post-translational modification has been the subject of intense study and that, with the advent of faster, more accurate instrumentation, the number of large-scale mass spectrometry-based phosphoproteomic studies has swelled over the past decade. Recent developments in sample preparation, phosphorylation enrichment, quantification, and data analysis strategies permit both targeted and ultra-deep phosphoproteome profiling, but challenges remain in pinpointing biologically relevant phosphorylation events. We describe here technological advances that have facilitated phosphoproteomic analysis of cells, tissues, and biofluids and note applications to neuropathologies in which the phosphorylation machinery may be dysregulated, much as it is in cancer.

Citing Articles

Lectins as a promising therapeutic agent for breast cancer: A review.

Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N Breast Dis. 2024; 43(1):193-211.

PMID: 38905027 PMC: 11307042. DOI: 10.3233/BD-230047.

Advances in post-translational modifications of proteins and cancer immunotherapy.

Li Y, Zhang R, Hei H Front Immunol. 2023; 14:1229397.

PMID: 37675097 PMC: 10477431. DOI: 10.3389/fimmu.2023.1229397.

A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer.

Liu P, Liu Z, Luo Q, Fu Q, Zhang X, Yu P Sci Rep. 2023; 13(1):13898.

PMID: 37626178 PMC: 10457314. DOI: 10.1038/s41598-023-41091-8.

State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer's Disease.

Rhea E, Leclerc M, Yassine H, Capuano A, Tong H, Petyuk V Aging Dis. 2023; 15(4):1688-1725.

PMID: 37611907 PMC: 11272209. DOI: 10.14336/AD.2023.0814.

Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer.

Wang Y, Zhang Y, Wang F, Li T, Song X, Shi H Sci Rep. 2022; 12(1):18518.

PMID: 36323715 PMC: 9630441. DOI: 10.1038/s41598-022-21328-8.

References

Lemeer S, Heck A . The phosphoproteomics data explosion. Curr Opin Chem Biol. 2009; 13(4):414-20. DOI: 10.1016/j.cbpa.2009.06.022. View

Ngounou Wetie A, Wormwood K, Russell S, Ryan J, Darie C, Woods A . A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder. Autism Res. 2015; 8(3):338-50. DOI: 10.1002/aur.1450. View

Yau R, Rape M . The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016; 18(6):579-86. DOI: 10.1038/ncb3358. View

Szalardy L, Zadori D, Simu M, Bencsik K, Vecsei L, Klivenyi P . Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity. J Neurol Sci. 2013; 331(1-2):38-42. DOI: 10.1016/j.jns.2013.04.024. View

McLafferty F, Breuker K, Jin M, Han X, Infusini G, Jiang H . Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics. FEBS J. 2007; 274(24):6256-68. DOI: 10.1111/j.1742-4658.2007.06147.x. View

Fort K, Dyachenko A, Potel C, Corradini E, Marino F, Barendregt A . Implementation of Ultraviolet Photodissociation on a Benchtop Q Exactive Mass Spectrometer and Its Application to Phosphoproteomics. Anal Chem. 2016; 88(4):2303-10. DOI: 10.1021/acs.analchem.5b04162. View

Xue L, Wang P, Cao P, Zhu J, Tao W . Identification of extracellular signal-regulated kinase 1 (ERK1) direct substrates using stable isotope labeled kinase assay-linked phosphoproteomics. Mol Cell Proteomics. 2014; 13(11):3199-210. PMC: 4223502. DOI: 10.1074/mcp.O114.038588. View

Shah K, Shokat K . A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathway. Chem Biol. 2002; 9(1):35-47. DOI: 10.1016/s1074-5521(02)00086-8. View

Park H, Lee K, Park E, Oh S, Yan R, Zhang J . Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies. Ann Clin Transl Neurol. 2016; 3(10):769-780. PMC: 5048387. DOI: 10.1002/acn3.337. View

10.

Kyono Y, Sugiyama N, Imami K, Tomita M, Ishihama Y . Successive and selective release of phosphorylated peptides captured by hydroxy acid-modified metal oxide chromatography. J Proteome Res. 2008; 7(10):4585-93. DOI: 10.1021/pr800305y. View

11.

Yu P, Pisitkun T, Wang G, Wang R, Katagiri Y, Gucek M . Global analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycans. PLoS One. 2013; 8(3):e59285. PMC: 3601063. DOI: 10.1371/journal.pone.0059285. View

12.

Erickson B, Rose C, Braun C, Erickson A, Knott J, McAlister G . A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization. Mol Cell. 2017; 65(2):361-370. PMC: 5250569. DOI: 10.1016/j.molcel.2016.12.005. View

13.

Zhou H, Ye M, Dong J, Corradini E, Cristobal A, Heck A . Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography. Nat Protoc. 2013; 8(3):461-80. DOI: 10.1038/nprot.2013.010. View

14.

Post H, Penning R, Fitzpatrick M, Garrigues L, Wu W, MacGillavry H . Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons. J Proteome Res. 2017; 16(2):728-737. DOI: 10.1021/acs.jproteome.6b00753. View

15.

Zanivan S, Meves A, Behrendt K, Schoof E, Neilson L, Cox J . In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep. 2013; 3(2):552-66. DOI: 10.1016/j.celrep.2013.01.003. View

16.

Knapp S, Sundstrom M . Recently targeted kinases and their inhibitors-the path to clinical trials. Curr Opin Pharmacol. 2014; 17:58-63. DOI: 10.1016/j.coph.2014.07.015. View

17.

Brettschneider J, Petzold A, Sussmuth S, Ludolph A, Tumani H . Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology. 2006; 66(6):852-6. DOI: 10.1212/01.wnl.0000203120.85850.54. View

18.

Hooper C, Killick R, Lovestone S . The GSK3 hypothesis of Alzheimer's disease. J Neurochem. 2007; 104(6):1433-9. PMC: 3073119. DOI: 10.1111/j.1471-4159.2007.05194.x. View

19.

Rost H, Sachsenberg T, Aiche S, Bielow C, Weisser H, Aicheler F . OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat Methods. 2016; 13(9):741-8. DOI: 10.1038/nmeth.3959. View

20.

Thingholm T, Jensen O, Robinson P, Larsen M . SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics. 2007; 7(4):661-71. DOI: 10.1074/mcp.M700362-MCP200. View